货号：UP648178044
| 产品信息 | |
| 产品名称： | Smo Inhibitor C24 |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 1567963-99-8 |
| 分子式： | C24H27ClN6O |
| 分子量： | 450.96 |
| MDL NO： | - |
| 标准纯度： | 98+% (UP648178044) |
| 沸点： | - |
| 储存： | (UP648178044) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
SNS-314 Mesylate
UP3829439101146618-41-8
Suloctidil
UP20661059754767-75-8
IC261
UP364582760186611-52-9
CCT137690
UP3297521241095382-05-0
PAP-1
UP348854274870653-45-5
MLN2480
UP1934466181096708-71-2
S49076
UP7673069451265965-22-7
SR-3029
UP4388602211454585-06-8
A 438079
UP463445550899507-36-9
JNJ-7706621
UP884018001443797-96-4
6-Nitrobenzo[d]isoxazole
UP23730661539835-08-0
IAA-94
UP42022253153108-00-2
HG-9-91-01
UP1436909411456858-58-4
GlyH-101
UP880288249328541-79-3
1-Benzyl-3-(bromomethyl)piperidine
UP867148632109859-83-8
Ivacaftor
UP603510320873054-44-5
Isothiazole-4-carbonitrile
UP6719166393912-37-6
D4476
UP309373352301836-43-1
Minoxidil
UP62209459338304-91-5
CFTR(inh)-172
UP159565974307510-92-5
PLX4720
UP511249934918505-84-7
2-Bromo-5-methylfuran
UP430719500123837-09-2
IMR-1A
UP646589429331862-41-0
Cortisone Acetate
UP19936733050-04-4
SCH772984
UP166203569942183-80-4
PLX7904
UP9219911471393465-84-3
Triamcinolone acetonide
UP89951939176-25-5
Bardoxolone methyl
UP185854377218600-53-4
R(+)-IAA-94
UP47609155654197-31-8
Encorafenib
UP7234287131269440-17-6
De-O-methyllasiodiplodin
UP23764749732885-82-8
PLX8394
UP8096682901393466-87-9
Sodium Butyrate
UP323381953156-54-7
A-740003
UP899533363861393-28-4
4-Benzylpiperidine
UP56552510931252-42-3
ZM336372
UP394042913208260-29-1
GW791343 trihydrochloride
UP591555071309712-55-8
CPI-613
UP38125591295809-78-2
CEP-32496 hydrochloride
UP3457140051227678-26-3
AMD-070 hydrochloride
UP456623129880549-30-4
KM11060
UP711492404774549-97-2
Gimeracil
UP575833287103766-25-2
3-Methyl-oxetane-3-carbaldehyde
UP36596972599419-31-5
Vernakalant Hydrochloride
UP414575151748810-28-8
Monomethyl Auristatin E
UP355440124474645-27-7
B-Raf IN 1
UP136430023950736-05-7
AZD1152-HQPA
UP932380616722544-51-6
VX-661
UP4425285721152311-62-0
VX-809
UP120175488936727-05-8
3-Methyloxetan-3-amine
UP340358314874473-14-0
SB-590885
UP651316197405554-55-4
Atglistatin
UP3830490831469924-27-3
PP121
UP8906660591092788-83-4
FTI-277
UP853241633170006-73-2
IOWH-032
UP7868447351191252-49-9
Selamectin
UP647482078220119-17-5
AZD3264
UP1665484361609281-86-8
Hydralazine hydrochloride
UP228869440304-20-1
ML264
UP2498983061550008-55-3
Mitiglinide Calcium
UP775191805145525-41-3
(2,4-Difluorophenyl)(piperidin-4-yl)methanone oxime hydrochloride
UP286337697135634-18-3
GAP-134
UP165678286943134-39-2
1-(5-(((2-Cyanoethyl)thio)methyl)thiazol-2-yl)guanidine
UP742144513131184-89-9
BAY 65-1942
UP852343697600734-02-9
Cinchocaine
UP47732954585-79-0
EMD 1214063
UP6677965281100598-32-0
Mifepristone
UP62698283684371-65-3
MK-5108
UP3479416431010085-13-8
Ulixertinib
UP223963569869886-67-9
1-(3-Methyloxetan-3-yl)ethanone
UP3289094451363381-04-7
Heliosterpenoid A
UP2876449242109805-68-5
Ridaforolimus
UP931478838572924-54-0
Dabrafenib Mesylate
UP2913709551195768-06-9
tert-Butyl 3-oxoazetidine-1-carboxylate
UP284774544398489-26-4
VX-11e
UP125363407896720-20-0
Mertansine
UP184520108139504-50-0
(DHQ)2AQN
UP136832623176097-24-8
Dofequidar fumarate
UP117315546153653-30-6
Smo Inhibitor C24
UP6481780441567963-99-8